Related references
Note: Only part of the references are listed.Systematic Review with Meta-Analysis: Fecal Microbiota Transplantation for Severe or Fulminant Clostridioides difficile
Emily N. Tixier et al.
DIGESTIVE DISEASES AND SCIENCES (2022)
Managing the Microbiome: How the Gut Influences Development and Disease
Noah Weinstein et al.
NUTRIENTS (2021)
Significant and Conflicting Correlation of IL-9 With Prevotella and Bacteroides in Human Colorectal Cancer
Elena Niccolai et al.
FRONTIERS IN IMMUNOLOGY (2021)
Diving into Inflammation: A Pilot Study Exploring the Dynamics of the Immune-Microbiota Axis in Ileal Tissue Layers of Patients with Crohn's Disease
Edda Russo et al.
JOURNAL OF CROHNS & COLITIS (2021)
A Comprehensive Overview of Colon Cancer- A Grim Reaper of the 21st Century
Rajesh Kumar et al.
CURRENT MEDICINAL CHEMISTRY (2021)
Influence of a 3-month low-calorie Mediterranean diet compared to the vegetarian diet on human gut microbiota and SCFA: the CARDIVEG Study
Giuditta Pagliai et al.
EUROPEAN JOURNAL OF NUTRITION (2020)
Review article: bacteriophages in gastroenterology-from biology to clinical applications
Joao Sabino et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
The mutual interplay of gut microbiota, diet and human disease
Placido Illiano et al.
FEBS JOURNAL (2020)
Role of gut microbiota-immunity axis in patients undergoing surgery for colorectal cancer: Focus on short and long-term outcomes
Ilenia Bartolini et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
Phages and Their Role in Gastrointestinal Disease: Focus on Inflammatory Bowel Disease
Martin Maronek et al.
CELLS (2020)
A link between inflammation and thrombosis in atherosclerotic cardiovascular diseases: Clinical and therapeutic implications
Evangelos Oikonomou et al.
ATHEROSCLEROSIS (2020)
Short-Chain Fatty Acids and Lipopolysaccharide as Mediators Between Gut Dysbiosis and Amyloid Pathology in Alzheimer's Disease
Moira Marizzoni et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Phage Therapy in Gastrointestinal Diseases
Beatriz Gutierrez et al.
MICROORGANISMS (2020)
Correlation between the Antimicrobial Activity and Metabolic Profiles of Cell Free Supernatants and Membrane Vesicles Produced by Lactobacillus reuteri DSM 17938
Alessandro Maccelli et al.
MICROORGANISMS (2020)
Role of gut microbiota in cardiovascular diseases
Marko Novakovic et al.
WORLD JOURNAL OF CARDIOLOGY (2020)
Pancreatic Cancer, Gut Microbiota, and Therapeutic Efficacy
Xiang Zhang et al.
JOURNAL OF CANCER (2020)
Fecal microbiota transplantation: Review and update
Jiunn-Wei Wang et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2019)
Microbiota transplantation: Targeting cancer treatment
Xia Wu et al.
CANCER LETTERS (2019)
Bacteriophages of the Human Gut: The Known Unknown'' of the Microbiome
Andrey N. Shkoporov et al.
CELL HOST & MICROBE (2019)
The negative impact of antibiotics on outcomes in cancer patients treated with immunotherapy: a new independent prognostic factor?
A. Elkrief et al.
ANNALS OF ONCOLOGY (2019)
Gut microbiota in colorectal cancer: mechanisms of action and clinical applications
Sunny H. Wong et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Healthy axis: Towards an integrated view of the gut-brain health
Federico Boem et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
FETR-ALS Study Protocol: A Randomized Clinical Trial of Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis
Jessica Mandrioli et al.
FRONTIERS IN NEUROLOGY (2019)
Use of Antibiotics and Risk of Cancer: A Systematic Review and Meta-Analysis of Observational Studies
Fausto Petrelli et al.
CANCERS (2019)
The lung microbiome: clinical and therapeutic implications
Alessio Fabbrizzi et al.
INTERNAL AND EMERGENCY MEDICINE (2019)
Small Intestinal Bacterial Overgrowth: Clinical Features and Therapeutic Management
Satish S. C. Rao et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2019)
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
V. Gopalakrishnan et al.
SCIENCE (2018)
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Bertrand Routy et al.
SCIENCE (2018)
Interplay between the lung microbiome and lung cancer
Qixing Mao et al.
CANCER LETTERS (2018)
Low-Calorie Vegetarian Versus Mediterranean Diets for Reducing Body Weight and Improving Cardiovascular Risk Profile CARDIVEG Study (Cardiovascular Prevention With Vegetarian Diet)
Francesco Sofi et al.
CIRCULATION (2018)
Biomedical applications of prokaryotic carbonic anhydrases
Claudiu T. Supuran et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2018)
Carbonic anhydrase activators
Claudiu T. Supuran
FUTURE MEDICINAL CHEMISTRY (2018)
Clostridium difficile Exposures, Colonization, and the Microbiome: Implications for Prevention
Sara L. Revolinski et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2018)
Crystal Structure of Carbonic Anhydrase II in Complex with an Activating Ligand: Implications in Neuronal Function
Avni Bhatt et al.
MOLECULAR NEUROBIOLOGY (2018)
The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients
Vyara Matson et al.
SCIENCE (2018)
Gut microbiota associations with common diseases and prescription medications in a population-based cohort
Matthew A. Jackson et al.
NATURE COMMUNICATIONS (2018)
Preliminary Comparison of Oral and Intestinal Human Microbiota in Patients with Colorectal Cancer: A Pilot Study
Edda Russo et al.
FRONTIERS IN MICROBIOLOGY (2018)
Association of Oral Microbiome With Risk for Incident Head and Neck Squamous Cell Cancer
Richard B. Hayes et al.
JAMA ONCOLOGY (2018)
I've Gut A Feeling: Microbiota Impacting the Conceptual and Experimental Perspectives of Personalized Medicine
Amedeo Amedei et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
A Wake-Up Call: We Need Phage Therapy Now
Karin Moelling et al.
VIRUSES-BASEL (2018)
The Brain-Gut-Microbiome Axis
Clair R. Martin et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2018)
Advances in structure-based drug discovery of carbonic anhydrase inhibitors
Claudiu T. Supuran
EXPERT OPINION ON DRUG DISCOVERY (2017)
A class of carbonic anhydrase I - selective activators
Erol Licsandru et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2017)
European consensus conference on faecal microbiota transplantation in clinical practice
Giovanni Cammarota et al.
GUT (2017)
Chemopreventive effects of a low-side-effect antibiotic drug, erythromycin, on mouse intestinal tumors
Takahiro Hamoya et al.
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2017)
Cloning, expression and purification of the α-carbonic anhydrase from the mantle of the Mediterranean mussel, Mytilus galloprovincialis
Rosa Perfetto et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2017)
Sulphonamide inhibition studies of the β-carbonic anhydrase from the bacterial pathogen Clostridium perfringens
Daniela Vullo et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2017)
An Overview of the Bacterial Carbonic Anhydrases
Claudiu T. Supuran et al.
METABOLITES (2017)
Faecal microbiota transplantation protects against radiation-induced toxicity
Ming Cui et al.
EMBO MOLECULAR MEDICINE (2017)
Burkholderia pseudomallei γ-carbonic anhydrase is strongly activated by amino acids and amines
Daniela Vullo et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
The Gut Microbiome in Human Neurological Disease: A Review
Helen Tremlett et al.
ANNALS OF NEUROLOGY (2017)
Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth
L. Gatta et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome
Francesca De Filippis et al.
GUT (2016)
A magnificent enzyme superfamily: carbonic anhydrases, their purification and characterization
Ozen Ozensoy Guler et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)
How many carbonic anhydrase inhibition mechanisms exist?
Claudiu T. Supuran
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)
Structure and function of carbonic anhydrases
Claudiu T. Supuran
BIOCHEMICAL JOURNAL (2016)
Synthesis of 4-(thiazol-2-ylamino)-benzenesulfonamides with carbonic anhydrase I, II and IX inhibitory activity and cytotoxic effects against breast cancer cell lines
Nagwa M. Abdel Gawad et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Sulfonamide inhibition studies of the β-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae
Sonia Del Prete et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Comparison of the sulfonamide inhibition profiles of the α-, β- and γ-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae
Sonia Del Prete et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Microbiome and Anticancer Immunosurveillance
Laurence Zitvogel et al.
CELL (2016)
Discovery of New Potential Anti-Infective Compounds Based on Carbonic Anhydrase Inhibitors by Rational Target-Focused Repurposing Approaches
Giannamaria Annunziato et al.
CHEMMEDCHEM (2016)
An Overview of the Carbonic Anhydrases from Two Pathogens of the Oral Cavity: Streptococcus mutans and Porphyromonas gingivalis
Clemente Capasso et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2016)
Effects of Antibiotics on Gut Microbiota
Kathleen Lange et al.
DIGESTIVE DISEASES (2016)
Drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors
Claudiu T. Supuran
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2016)
Carbonic anhydrase inhibition and the management of neuropathic pain
Claudiu T. Supuran
EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)
A substituted sulfonamide and its Co (II), Cu (II), and Zn (II) complexes as potential antifungal agents
Jorge R. A. Diaz et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)
Cloning, expression and purification of the complete domain of the η-carbonic anhydrase from Plasmodium fakiparum
Sonia Del Prete et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)
New light on bacterial carbonic anhydrases phylogeny based on the analysis of signal peptide sequences
Claudiu T. Supuran et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)
Reduction of Murine Colon Tumorigenesis Driven by Enterotoxigenic Bacteroides fragilis Using Cefoxitin Treatment
Christina E. DeStefano Shields et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Carbonic anhydrase inhibition and the management of neuropathic pain
Claudiu T. Supuran
EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)
The Gut Microbiota and Immune System Relationship in Human Graft-versus-Host Disease
Lucrezia Laterza et al.
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES (2016)
Legionella pneumophila Carbonic Anhydrases: Underexplored Antibacterial Drug Targets
Claudiu T. Supuran
PATHOGENS (2016)
Fecal Microbiota Transplantation: Current Applications, Effectiveness, and Future Perspectives
Hyun Ho Choi et al.
CLINICAL ENDOSCOPY (2016)
Sulfonamide inhibition studies of the η-class carbonic anhydrase from the malaria pathogen Plasmodium falciparum
Daniela Vullo et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Sulfonamide inhibition studies of the γ-carbonic anhydrase from the Antarctic bacterium Pseudoalteromonas haloplanktis
Daniela Vullo et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Sulfonamide inhibition study of the β-class carbonic anhydrase from the caries producing pathogen Streptococcus mutans
Nurcan Dedeoglu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
An Overview of the Selectivity and Efficiency of the Bacterial Carbonic Anhydrase Inhibitors
C. Capasso et al.
CURRENT MEDICINAL CHEMISTRY (2015)
Bacterial, fungal and protozoan carbonic anhydrases as drug targets
Clemente Capasso et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
Binding of the Fap2 Protein of Fusobacterium nucleatum to Human Inhibitory Receptor TIGIT Protects Tumors from Immune Cell Attack
Chamutal Gur et al.
IMMUNITY (2015)
Determination of Rifaximin Treatment Period According to Lactulose Breath Test Values in Nonconstipated Irritable Bowel Syndrome Subjects
Suhyun Bae et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2015)
Glucose breath test and Crohn's disease: Diagnosis of small intestinal bacterial overgrowth and evaluation of therapeutic response
Anna Greco et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2015)
Duodenal Aspirates for Small Intestine Bacterial Overgrowth: Yield, PPIs, and Outcomes after Treatment at a Tertiary Academic Medical Center
Diana L. Franco et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2015)
The vocabulary of microbiome research: a proposal
Julian R. Marchesi et al.
MICROBIOME (2015)
The η-class carbonic anhydrases as drug targets for antimalarial agents
Claudiu T. Supuran et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
Inhibition of human carbonic anhydrase isozymes I, II, IX and XII with a new series of sulfonamides incorporating aroylhydrazone-, [1,2,4]triazolo[3,4-b][1,3,4]thiadiazinyl- or 2-(cyanophenylmethylene)-1,3,4-thiadiazol-3(2H)-yl moieties
Ahmed M. Alafeefy et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2015)
Inhibition studies of quinazoline-sulfonamide derivatives against the γ-CA (PgiCA) from the pathogenic bacterium, Porphyromonas gingivalis
Ahmed M. Alafeefy et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2015)
An overview of the alpha-, beta- and gamma-carbonic anhydrases from Bacteria: can bacterial carbonic anhydrases shed new light on evolution of bacteria?
Clemente Capasso et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2015)
Sulfonamide inhibition studies of two β-carbonic anhydrases from the bacterial pathogen Legionella pneumophila
Isao Nishimori et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Sulfa and trimethoprim-like drugs - antimetabolites acting as carbonic anhydrase, dihydropteroate synthase and dihydrofolate reductase inhibitors
Clemente Capasso et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2014)
Rifaximin for small intestinal bacterial overgrowth in patients without irritable bowel syndrome
Doron Boltin et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2014)
Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth
S. C. Shah et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Anion inhibition studies of a β-carbonic anhydrase from Clostridium perfringens
Daniela Vullo et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
The extremo-α-carbonic anhydrase (CA) from Sulfurihydrogenibium azorense, the fastest CA known, is highly activated by amino acids and amines
Atilla Akdemir et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
Aleksandar D. Kostic et al.
CELL HOST & MICROBE (2013)
Fusobacterium nucleatum Promotes Colorectal Carcinogenesis by Modulating E-Cadherin/β-Catenin Signaling via its FadA Adhesin
Mara Roxana Rubinstein et al.
CELL HOST & MICROBE (2013)
Elevated serum IL-22 levels correlate with chemoresistant condition of colorectal cancer
Tingyu Wu et al.
CLINICAL IMMUNOLOGY (2013)
Probiotic bacteria in cancer patients undergoing chemotherapy and radiation therapy
Michal Mego et al.
COMPLEMENTARY THERAPIES IN MEDICINE (2013)
Anti-infective carbonic anhydrase inhibitors: a patent and literature review
Clemente Capasso et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2013)
Carbonic anhydrases: from biomedical applications of the inhibitors and activators to biotechnological use for CO2 capture
Claudiu T. Supuran
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2013)
A Mixture of trans-Galactooligosaccharides Reduces Markers of Metabolic Syndrome and Modulates the Fecal Microbiota and Immune Function of Overweight Adults
Jelena Vulevic et al.
JOURNAL OF NUTRITION (2013)
A PROBIOTICS-CONTAINING BISCUIT MODULATES THE INTESTINAL MICROBIOTA IN THE ELDERLY
S. Rampelli et al.
JOURNAL OF NUTRITION HEALTH & AGING (2013)
Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis
Robert A. Koeth et al.
NATURE MEDICINE (2013)
Human gut microbiome viewed across age and geography
Tanya Yatsunenko et al.
NATURE (2012)
Toward an Understanding of Changes in Diversity Associated with Fecal Microbiome Transplantation Based on 16S rRNA Gene Deep Sequencing
Dea Shahinas et al.
MBIO (2012)
Carbonic anhydrase inhibitors and activators for novel therapeutic applications
Claudiu T. Supuran
FUTURE MEDICINAL CHEMISTRY (2011)
Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes
Gary D. Wu et al.
SCIENCE (2011)
Carbonic Anhydrase Inhibition/Activation: Trip of a Scientist Around the World in the Search of Novel Chemotypes and Drug Targets
Claudiu T. Supuran
CURRENT PHARMACEUTICAL DESIGN (2010)
The beta-Carbonic Anhydrases from Mycobacterium tuberculosis as Drug Targets
Isao Nishimori et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa
Carlotta De Filippo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active β-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c
Fabrizio Carta et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Carbonic anhydrase activation and the drug design
Claudia Temperini et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Microbial influences in inflammatory bowel diseases
R. Balfour Sartor
GASTROENTEROLOGY (2008)
Next-generation DNA sequencing
Jay Shendure et al.
NATURE BIOTECHNOLOGY (2008)
Clostridium difficile— More Difficult Than Ever
Ciarán P. Kelly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Carbonic anhydrase activators. Activation of isozymes I, II, IV, VA, VII, and XIV with L- and D-histidine and crystallographic analysis of their adducts with isoform II: Engineering proton-transfer processes within the active site of an enzyme
Claudia Temperini et al.
CHEMISTRY-A EUROPEAN JOURNAL (2006)
The gut flora as a forgotten organ
Ann M. O'Hara et al.
EMBO REPORTS (2006)
Carbonic anhydrase activators: X-ray crystal structure of the adduct of human isozyme II with L-histidine as a platform for the design of stronger activators
C Temperini et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Ciprofloxacin suppresses bacterial overgrowth, increases fasting insulin but does not correct low acylated ghrelin concentration in non-alcoholic steatohepatitis
A Sajjad et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Diversity of the human intestinal microbial flora
PB Eckburg et al.
SCIENCE (2005)
Getting a grip on things: how do communities of bacterial symbionts become established in our intestine?
JL Sonnenburg et al.
NATURE IMMUNOLOGY (2004)
Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn's disease
F Castiglione et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Functional food concept and its application to prebiotics
M Roberfroid
DIGESTIVE AND LIVER DISEASE (2002)
Free energy determinants of tertiary structure and the evaluation of protein models
D Petrey et al.
PROTEIN SCIENCE (2000)
Share Paper
